MMED
MiniMed Surpasses $3 Billion in Revenue as First Publicly Traded Insulin Pump Manufacturer
MiniMed, a leading manufacturer of insulin pumps and automated insulin delivery systems, has made history by surpassing the $3 billion mark in revenue for fiscal 2026. This significant milestone was achieved through the company's focus on driving pipeline execution over the last few years. In its first quarter